Q1 EPS Estimates for Astera Labs Lifted by Northland Capmk

Astera Labs, Inc. (NASDAQ:ALAB - Free Report) - Equities research analysts at Northland Capmk lifted their Q1 2025 earnings per share estimates for Astera Labs in a research note issued to investors on Tuesday, February 11th. Northland Capmk analyst G. Richard now forecasts that the company will post earnings of $0.06 per share for the quarter, up from their previous estimate of ($0.01). Northland Capmk currently has a "Strong-Buy" rating on the stock. The consensus estimate for Astera Labs' current full-year earnings is ($0.45) per share. Northland Capmk also issued estimates for Astera Labs' Q2 2025 earnings at $0.07 EPS, Q3 2025 earnings at $0.06 EPS, Q4 2025 earnings at $0.07 EPS, FY2025 earnings at $0.25 EPS and FY2026 earnings at $0.61 EPS.

Astera Labs (NASDAQ:ALAB - Get Free Report) last posted its earnings results on Monday, February 10th. The company reported $0.10 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.26 by ($0.16). Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%.

ALAB has been the topic of several other reports. Deutsche Bank Aktiengesellschaft lifted their price target on Astera Labs from $60.00 to $100.00 and gave the company a "buy" rating in a research report on Tuesday, November 5th. Northland Securities upgraded Astera Labs from a "market perform" rating to an "outperform" rating and set a $120.00 price target on the stock in a research report on Tuesday, January 28th. Citigroup initiated coverage on Astera Labs in a research report on Monday, November 18th. They set a "buy" rating and a $120.00 price target on the stock. Barclays lifted their price target on Astera Labs from $87.00 to $135.00 and gave the company an "overweight" rating in a research report on Friday, January 17th. Finally, Craig Hallum lifted their price target on Astera Labs from $105.00 to $125.00 and gave the company a "buy" rating in a research report on Tuesday, February 11th. One equities research analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat.com, the stock currently has an average rating of "Buy" and an average price target of $115.33.

Astera Labs Trading Up 6.2 %

Shares of NASDAQ ALAB traded up $5.42 during mid-day trading on Friday, hitting $93.27. 6,122,987 shares of the stock traded hands, compared to its average volume of 5,587,622. Astera Labs has a 52 week low of $36.22 and a 52 week high of $147.39. The stock has a fifty day moving average price of $119.48 and a 200-day moving average price of $84.12.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Whittier Trust Co. of Nevada Inc. purchased a new stake in Astera Labs during the fourth quarter valued at $25,000. Hollencrest Capital Management purchased a new stake in Astera Labs during the third quarter valued at $26,000. Steward Partners Investment Advisory LLC increased its position in Astera Labs by 99.0% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 199 shares of the company's stock valued at $26,000 after acquiring an additional 99 shares during the last quarter. Kestra Investment Management LLC purchased a new stake in Astera Labs during the fourth quarter valued at $28,000. Finally, Geneos Wealth Management Inc. purchased a new stake in Astera Labs during the fourth quarter valued at $36,000. 60.47% of the stock is owned by institutional investors.

Insider Activity

In other news, Director Stefan A. Dyckerhoff sold 7,814 shares of the company's stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $107.17, for a total transaction of $837,426.38. Following the transaction, the director now directly owns 121,803 shares of the company's stock, valued at $13,053,627.51. This represents a 6.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Jitendra Mohan sold 171,064 shares of the company's stock in a transaction on Thursday, November 21st. The shares were sold at an average price of $103.53, for a total value of $17,710,255.92. Following the transaction, the chief executive officer now directly owns 628,895 shares in the company, valued at approximately $65,109,499.35. The trade was a 21.38 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 639,244 shares of company stock valued at $67,669,886 over the last ninety days.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.